Kenneth B Christopher1. 1. The Nathan E. Hellman Memorial Laboratory, Division of Renal Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: Although low vitamin D levels have been shown to be a risk factor for adverse outcomes in critical care, it is not clear to date if supplementation can alter such outcomes in all ICU patients. The focus of vitamin D research now is on interventional trials to identify a critically ill patient subset who may benefit from high-dose vitamin D supplementation. RECENT FINDINGS: The VITdAL-ICU trial, a randomized, double-blind, placebo-controlled, single center trial of 475 heterogeneous critically ill patients, did not show improvement in hospital length of stay or overall mortality but did demonstrate in a secondary outcome that high-dose oral vitamin D3 improved mortality in patients with severe vitamin D deficiency. SUMMARY:Vitamin D supplementation may represent a personalized and targeted therapy for critical illness. Vitamin D regulates over 1000 genes in the human genome, and the mechanism of action is influenced by gene polymorphisms and epigenetics. The study of the metabolomics, transcriptomics and epigenetics of vitamin D status and supplementation holds promise generating insights into critical illness outcomes.
RCT Entities:
PURPOSE OF REVIEW: Although low vitamin D levels have been shown to be a risk factor for adverse outcomes in critical care, it is not clear to date if supplementation can alter such outcomes in all ICU patients. The focus of vitamin D research now is on interventional trials to identify a critically ill patient subset who may benefit from high-dose vitamin D supplementation. RECENT FINDINGS: The VITdAL-ICU trial, a randomized, double-blind, placebo-controlled, single center trial of 475 heterogeneous critically ill patients, did not show improvement in hospital length of stay or overall mortality but did demonstrate in a secondary outcome that high-dose oral vitamin D3 improved mortality in patients with severe vitamin D deficiency. SUMMARY:Vitamin D supplementation may represent a personalized and targeted therapy for critical illness. Vitamin D regulates over 1000 genes in the human genome, and the mechanism of action is influenced by gene polymorphisms and epigenetics. The study of the metabolomics, transcriptomics and epigenetics of vitamin D status and supplementation holds promise generating insights into critical illness outcomes.
Authors: Edwin Hoe; Jordan Nathanielsz; Zheng Quan Toh; Leena Spry; Rachel Marimla; Anne Balloch; Kim Mulholland; Paul V Licciardi Journal: Nutrients Date: 2016-12-12 Impact factor: 5.717
Authors: M Herly; K Stengaard-Pedersen; K Hørslev-Petersen; M L Hetland; M Østergaard; R Christensen; B B Løgstrup; P Vestergaard; J Pødenphant; P Junker; T Ellingsen Journal: BMJ Open Date: 2017-04-08 Impact factor: 2.692
Authors: Jessica Lasky-Su; Amber Dahlin; Augusto A Litonjua; Angela J Rogers; Michael J McGeachie; Rebecca M Baron; Lee Gazourian; Diana Barragan-Bradford; Laura E Fredenburgh; Augustine M K Choi; Kris M Mogensen; Sadeq A Quraishi; Karin Amrein; Kenneth B Christopher Journal: Crit Care Date: 2017-07-28 Impact factor: 9.097
Authors: Lourdes Herrera-Quintana; Yenifer Gamarra-Morales; Héctor Vázquez-Lorente; Jorge Molina-López; José Castaño-Pérez; Juan Francisco Machado-Casas; Ramón Coca-Zúñiga; José Miguel Pérez-Villares; Elena Planells Journal: Nutrients Date: 2021-06-09 Impact factor: 5.717